From Modis to AKKODiS: Transformation into Consulting Firm - 01 December 2022 19:00

TOKYO, Dec. 1, 2022 /Kyodo JBN-AsiaNet/-- - End-to-end Consulting Services to Support Innovation within Organizations - Modis Ltd. (hereinafter "Modis"), a Tokyo-based technology solution provider and group company of the Adecco Group, the global leader in human resource services, will...

  Encore Medical Education announces publication of the Official... - 01 December 2022 18:45

SAN ANTONIO, Dec. 1, 2022 /PRNewswire-AsiaNet/ -- - Best of SABCS(R) News Highlights coverage will provide daily expert video summaries along with original presentation slides of the most significant breast cancer trials for oncologists worldwide. Encore Medical Education [http://www.encor...

  "humy with Charlie Puth" -- Subscription-based Communication S... - 01 December 2022 17:00

TOKYO, Dec. 1, 2022 /Kyodo JBN-Asianet/ -- MIXI, Inc. is proud to announce the launch of humy, a subscription-based platform specializing in communications between artists and fans, on December 2, 2022. Logo of humy: https://kyodonewsprwire.jp/prwfile/release/M102029/202211250405/_prw_P...

  Ampcontrol Joins BHP in Canada on Project Vital to Global Food... - 01 December 2022 16:01

SYDNEY, Dec.1/Medianet International-AsiaNet/-- Ampcontrol has been named the supplier for conveyor control systems for Stage 1 at the BHP Jansen Potash Project in Saskatchewan, Canada. Predominantly used as a fertiliser, potash provides a rich source of potassium which keeps soils fertile a...

  Polyplastics Develops New Void Prediction Technology for Injec... - 01 December 2022 16:00

TOKYO, Dec. 1, 2022 /Kyodo JBN-Asianet/ -- Polyplastics Co., Ltd., a leading global supplier of engineering thermoplastics, has developed unique CAE analysis technology that predicts the occurrence of vacuum voids in injection-molded products made of DURACON (R) POM. This new CAE tool can ...

  New CRISPR/Cas9 license agreement for ERS Genomics and Cosmo Bio - 01 December 2022 11:00

DUBLIN, Dec. 1, 2022 /PRNewswire-AsiaNet/ -- ERS Genomics Limited ('ERS') is pleased to announce a new license agreement with Cosmo Bio. This is a non-exclusive license agreement granting Japan's Cosmo Bio access to the ERS CRISPR/Cas9 patent portfolio. ERS, co-founded by Dr. Emmanuelle C...

  LUCIDITY phase 3 topline data presented at CTAD for HMTM – the... - 01 December 2022 09:13

ABERDEEN, Scotland and SINGAPORE, Nov. 30, 2022 /PRNewswire-AsiaNet/ -- - Tau aggregation inhibitor, HMTM, is an oral drug with a strong safety profile, having no risk of amyloid related imaging abnormalities - Topline results for the Phase 3 study, LUCIDITY, were shared at the Clinical Trials in Alzheimer's Diseas...

  Global Citizen Forum delivers a first-of-its-kind immersive Su... - 01 December 2022 06:52

RAS AL KHAIMAH, UAE, Nov. 30, 2022 /PRNewswire-AsiaNet/ -- - 650+ guests from more than 90 countries attended the immersive two-day event - "Together, we can transform the world" – Ricky Martin - GLOBAL CITIZEN FORUM ANNUAL SUMMIT MEDIA GALERY [ https://global-citizen-forum.prezly.com/media ] Held u...

  Menarini Group Presents Updated Results from Pivotal Phase 3 E... - 01 December 2022 03:52

FLORENCE, Italy, November, 30, 2022, /PRNewswire-AsiaNet/-- • Elacestrant demonstrated longer progression-free survival (PFS) vs SOC endocrine therapy with medians up to 8.6 months, positively associated with the duration of prior treatment with CDK4/6 inhibitors • Elacestrant side effects were manageable...

  KENNAMETAL INTRODUCES NEXT-LEVEL INNOVATIONS - 01 December 2022 03:49

PITTSBURGH, Dec. 1, 2022 /PRNewswire-AsiaNet/ -- -- New and enhanced products expand metal cutting capabilities and help customers machine better than ever Kennametal has expanded its Innovations series of Metal Cutting tools and solutions with new product offerings that provide customers wit...